Dmitriy Genkin
Vermögen: 215 662 $ am 31.05.2026
Vermögen: 215 662 $ am 31.05.2026
Dr. Dmitriy D.
Genkin, MD, is an Executive Chairman at Pharmsynthez PJSC, a Managing Director at FDS Pharma LLP and a Director & Partner at FDS Pharma Associates Ltd. He is on the Board of Directors at Kevelt AS, SynBio LLC, EPhaG AS, CLS Therapeutics, Inc., Peri-Ness Technologies Ltd., Santersus AG, FDS Pharma Associates Ltd. and Xenetic Biosciences, Inc. Dr. Genkin was previously employed as a Non-Executive Director by Xenetic Biosciences, Inc., a Non-Executive Director by Human Stem Cells Institute OJSC, a Non-Executive Director by Xenetic Biosciences, Inc., and a Professor by University College London.
He also served on the board at Xenetic Biosciences Plc.
He received his undergraduate degree from Mechnikov St Petersburg State Medical Academy and a graduate degree from The School of Pharmacy University of London.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.10.2025 | 68.464 ( 2,99 % ) | 215 662 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| PHARMSYNTHEZ | Vorsitzender | 01.01.2005 |
| XENETIC BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | - |
Peri-Ness Technologies Ltd.
Peri-Ness Technologies Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company focusing on addressing the problems of male fertility | Direktor/Vorstandsmitglied | - |
SANTERSUS AG
SANTERSUS AG Medical SpecialtiesHealth Technology Develops novel patent protected transformative, lifesaving and blood purification devices | Gründer | - |
SynBio LLC
SynBio LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Direktor/Vorstandsmitglied | 01.01.2011 |
Kevelt AS
Kevelt AS Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Direktor/Vorstandsmitglied | 01.01.2013 |
FDS Pharma LLP
FDS Pharma LLP Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Vorstandsvorsitzender | 01.01.2003 |
EPhaG AS
EPhaG AS Drugstore ChainsRetail Trade Operates as a holding company for pharmacies | Direktor/Vorstandsmitglied | 01.01.2007 |
FDS Pharma Associates Ltd. | Direktor/Vorstandsmitglied | 17.11.2010 |
| ░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 15 |
|---|---|
University College London
University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xenetic Biosciences (UK) Ltd.
Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
FDS Pharma Associates Ltd. | |
EPhaG AS
EPhaG AS Drugstore ChainsRetail Trade Operates as a holding company for pharmacies | Retail Trade |
Pharmsynthez PJSC
Pharmsynthez PJSC Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Artgen Biotech PJSC
Artgen Biotech PJSC Medical/Nursing ServicesHealth Services Provides genetic testing & research, COVID-19 testing, reproductive medicine and regenerative medicine services | Health Services |
Peri-Ness Technologies Ltd.
Peri-Ness Technologies Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company focusing on addressing the problems of male fertility | Health Technology |
Kevelt AS
Kevelt AS Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
FDS Pharma LLP
FDS Pharma LLP Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
SynBio LLC
SynBio LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Mechnikov St Petersburg State Medical Academy
Mechnikov St Petersburg State Medical Academy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xenetic Biosciences, Inc.
Xenetic Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops biologic drugs, novel oncology therapeutics, and vaccinations | Health Technology |
The School of Pharmacy University of London
The School of Pharmacy University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CLS THERAPEUTICS, INC.
CLS THERAPEUTICS, INC. Pharmaceuticals: MajorHealth Technology CLS Therapeutics, Inc. is a biopharmaceutical company specializing in anticancer gene therapies targeting circulating cell-free DNA (cfDNA) and neutrophil extracellular traps (NETs), which contribute to tumor progression and therapy resistance. The company is based in New York, NY. The company's lead candidate, CLS-014, is an adeno-associated viral vector delivering a recombinant human DNase I enzyme to the liver, enabling hepatocytes to degrade harmful cfDNA in the bloodstream and tumor microenvironment. This approach aims to inhibit tumor growth and metastasis, with an initial focus on advanced pancreatic cancer. | Health Technology |
SANTERSUS AG
SANTERSUS AG Medical SpecialtiesHealth Technology Develops novel patent protected transformative, lifesaving and blood purification devices | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen